Considering that increased levels of suPAR are connected with asthma prevalence [27] and that increased alveolar infiltration of MCTC is a fingerprint of asthmatic disease severity [2], the chymase effect of suPAR is a highly interesting target for future validation in asthmatic disease. Here, CMA1 is linked to asthma.